Jaime Nelson Denson
Psychiatric/Mental Health · Austin, TXNPI 1326327313
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $62,860 of the $87,568 with a category attached, or 71.8%. 26 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 58.2% of the total. 2025 is the largest year on record at $53,451, more than ten times the $1,821 reported in 2021. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 608 payments — averaging $144.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$51K
- AbbVie$29K
- Alkermes, Inc.$2K
- Johnson & Johnson$885
- Corium, LLC$744
- Lundbeck LLC$637
- plus $3K from 20 others
What the payments were for
- Consulting fees$3,0003%
- Speaking & faculty fees$62,86072%
- Travel & lodging$8,1689%
- Food & beverage$13,49015%
- Education$500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 179 | $50,986 |
| AbbVie | 160 | $28,873 |
| Alkermes, Inc. | 53 | $2,241 |
| Johnson & Johnson | 37 | $885 |
| Corium, LLC | 37 | $744 |
| Lundbeck LLC | 36 | $637 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 21 | $608 |
| E.r. Squibb & Sons, L.L.C. | 8 | $436 |
| Axsome Therapeutics, Inc. | 12 | $415 |
| Supernus Pharmaceuticals, Inc. | 4 | $245 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $241 |
| Lilly USA, LLC | 2 | $210 |
| Bausch Health US, LLC | 9 | $178 |
| Vanda Pharmaceuticals Inc. | 9 | $171 |
| Teva Pharmaceuticals USA, Inc. | 3 | $151 |
| Neurocrine Biosciences, Inc. | 3 | $84 |
| Sunovion Pharmaceuticals Inc. | 5 | $82 |
| Noven Therapeutics, LLC | 4 | $80 |
| Tris Pharma Inc | 4 | $77 |
| Idorsia Pharmaceuticals US Inc | 4 | $74 |
| Avanir Pharmaceuticals, Inc. | 2 | $39 |
| Neos Therapeutics, LP | 2 | $31 |
| Biogen | 1 | $26 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| Brainsway USA Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$47,845
- VRAYLAR$26,639
- LYBALVI$3,299
- ARISTADA$1,405
- ARISTADA INITIO$351
- COBENFY$329
- SPRAVATO$277
- QELBREE$162
- Auvelity$125
- ABILIFY ASIMTUFII$121
- ABILIFY MAINTENA$121
- ZEPBOUND$116
- Austedo XR$102
How this compares
$87,568 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 11 | $98,853 |
| Olanzapine | 32 | $869 |
| Mirtazapine | 28 | $294 |
| Bupropion XlBupropion Hcl | 12 | $174 |
| Clonazepam | 20 | $113 |
| Lamotrigine | 13 | $89 |
| Fluoxetine Hcl | 15 | $72 |
| Diazepam | 15 | $40 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $84 | $98,85311 claims |
| Lilly USA, LLCOlanzapine | $210 | $86932 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in Austin
- Camille WatsonAustin$34K
- Suzanne GranthamAustin$31K
- Lin CaiAustin$16K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.